Skip to main content
. 2022 Mar 28;41(7):2171–2178. doi: 10.1007/s10067-022-06133-y

Table 1.

Clinical and clinimetric features of enrolled subjects

Total (n = 201) Females (n = 172) Males (n = 29) p value
Age (years) 49.13 (25–65) 49.07 (31–63) 49.22 (25–65) Ns
Triggering event, % 56.2 57.4 48.2 Ns
Headache, % 80.5 82.5 68.9 Ns
Abdominal pain, % 78.6 81.9 58.6 0.0046*
Depressive symptoms, % 50.2 51.9 72.4 0.0386*
WPI 10.7 ± 4.03 10.67 ± 3.91 10.90 ± 4.81 Ns
SSS 9.17 ± 1.73 9.24 ± 1.72 8.724 ± 1.79 Ns
R-FIQ Score 66.21 ± 16.97 68.07 ± 16.06 55.17 ± 18.26 0.0005*
R-FIQ Pain 7.36 ± 1.74 7.5 ± 1.64 6.52 ± 2.06 0.0130*
R-FIQ Fatigue 7.94 ± 1.92 8.08 ± 1.82 7.07 ± 2.25 0.0141*
R-FIQ Stiffness 7.63 ± 1.99 7.74 ± 1.83 6.97 ± 2.69 Ns
R-FIQ Sleep 7.7 ± 2.33 7.76 ± 2.31 7.38 ± 2.47 Ns
R-FIQ Depression 4.9 ± 2.77 4.83 ± 2.82 5.31 ± 2.49 Ns
R-FIQ Memory 6.23 ± 2.47 6.42 ± 2.42 5.1 ± 2.48 0.0077*
R-FIQ Anxiety 6.22 ± 2.83 6.18 ± 2.89 6.45 ± 2.47 Ns
R-FIQ Tenderness 7.55 ± 2.09 7.8 ± 1.95 6.07 ± 2.82  < 0.0001*
R-FIQ Balance 6.05 ± 2.54 6.35 ± 2.42 4.28 ± 2.52  < 0.0001*
R-FIQ Env. Sensitivity 7.51 ± 2.24 7.7 ± 2.10 6.41 ± 2.68 0.0128*
BDI-II 22.88 ± 9.18 22.95 ± 9.47 22.45 ± 7.36 Ns

Data are reported as mean ± SD, unless stated otherwise. *p values intended for comparisons between female and male participants. Abbreviations: WPI, widespread pain index; SSS, symptoms severity scale; R-FIQ, revised fibromyalgia impact questionnaire; BDI-II, Beck depression inventory-II.